Byron Nash Renal Medullary Carcinoma Awareness Act of 2015
Do you support it?
Want to know if it passes?
We'll email you when HR 3347 moves — a committee vote, a floor vote, or a signature. Nothing else.
Free forever · unsubscribe in one click.
Your answer was recorded either way.
Which district are you in?
Your ZIP is all we need to match you to your own representatives — so we can tell you how they voted on HR 3347.
You're tracking HR 3347
We'll email you the moment it moves.
HR 3347 — Byron Nash Renal Medullary Carcinoma Awareness Act of 2015
Last action — Referred to the Subcommittee on Health.
No card. One bill, free forever — alerts when it moves.
-
✓Introduced
-
✓In Committee
-
Died in session
This bill died with 114th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
This bill is no longer active — its legislative session has ended, so there is no live prognosis. It would have to be reintroduced in the current session to move again.
Summary
Byron Nash Renal Medullary Carcinoma Awareness Act of 2015 This bill amends title XIX (Medicaid) of the Social Security Act to pay states 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.
Bill Text
We don't have the full text on file for this bill yet.
Read HR 3347 on the official United States source →Action History
-
Referred to the Subcommittee on Health.
-
Referred to the House Committee on Energy and Commerce.
-
Introduced in House
Sponsors
- Al Green · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 546 not signed on
Sponsors (1)
- Al Green D
Co-sponsors (0)
None.
Not signed on (546)
546 members have not signed on to this bill.
Show all 546 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HR 3347 do?
- Byron Nash Renal Medullary Carcinoma Awareness Act of 2015 This bill amends title XIX (Medicaid) of the Social Security Act to pay states 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.
- Who sponsors HR 3347?
- HR 3347 is sponsored by Al Green (D).
- What is the current status of HR 3347?
- This bill died with 114th Congress. It reached “In Committee” and never advanced before the session ended, so it can no longer move — a new version would have to be reintroduced in the current session.
- Where can I track HR 3347?
- Track HR 3347 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HR 3347
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HR 3347
Last checked for changes about 8 hours ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →